IMNP starting a run on long awaited news. http://ih.advfn.com/p.php?pid=nmona&article=73892502&symbol=IMNP Immune Pharmaceuticals Announces the launch of REMAIN ™ , an international Overall Survival study with Ceplene® and low dose Proleukin® in REmission MAINtenance in Acute Myeloid Leukemia